Health-Related Quality of Life in Patients With Metastatic Basal Cell Carcinoma TreatedWith Cemiplimab: Analysis of a Phase 2 Open-Label Clinical Trial
07:30am - 03:45pm EDT - March 31, 2023
07:30am - 03:45pm EDT - March 31, 2023
Author(s):
- Karl D. Lewis, MD, University of Colorado Cancer Center
Tags: Member Institution Outcomes and Health Services Research
| Display Label | Action |
|---|---|
| 055-General Poster Session | Download Handout |
